Editorial: risk of loss of response to anti-TNFalpha agents in patients with inflammatory bowel disease-the longer the less? Goren I, Yanai H. Aliment Pharmacol Ther 2022;55:244-245.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goren I, Yanai H. Editorial: risk of loss of response to anti-TNFalpha agents in patients with inflammatory bowel disease-the longer the less? Aliment Pharmacol Ther 2022;55:244-245.
PMID: 34970768